Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Acq. announced
|
|
Bionano Genomics, Inc. (BNGO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/08/2021 |
8-K/A
| Quarterly results |
| 11/03/2020 |
8-K/A
| Financial Statements and Exhibits|
Docs:
|
"Consent of Tanner LLC, independent registered public accounting firm",
"Audited financial statements of Lineagen as of and for the years ended December 31, 2019 and 2018, and unaudited interim financial statements of Lineagen as of June 30, 2020 and for the six months ended June 30, 2020 and 2019",
"Unaudited pro forma consolidated combined balance sheet for the Company and Lineagen as of June 30, 2020 and unaudited pro forma consolidated combined statements of operations for the Company and Lineagen for the year ended December 31, 2019 and for the six months ended June 30, 2020" |
|
| 09/30/2020 |
8-K/A
| Quarterly results |
|
|